One of the most advantageous aspects of conducting clinical trials in Australia & New Zealand is the expeditious regulatory ‘notification-only’ scheme, which enables companies to initiate even first in human clinical trials quickly.
With a streamlined national ethics committee application system in both countries, sites are initiated on average within 4-6 weeks submission.
High quality data, state of the art clinical sites, and a healthy, ageing population makes ANZ a highly attractive area for clinical research.
Join Suzanne Williams, of Mobius Medical as she partners with Brandwood Biomedical to talk about how the ‘notification-only’ scheme works for clinical trials conducted in ANZ!
Date: Wednesday 21st October 2015
Time: 8.00 – 9.00am Australian Eastern Standard Time
